or Try an Advanced Search...

    Technical Analysis for ABSI - Absci Corporation

    Grade Last Price % Change Price Change
    D 4.94 -1.20% -0.06
    ABSI closed down 1.2 percent on Wednesday, May 8, 2024, on 24 percent of normal volume.
    Earnings due: May 14
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical ABSI trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Fell Below 20 DMA Bearish -1.20%
    Fell Below 50 DMA Bearish -1.20%
    Wide Bands Range Expansion -1.20%
    Crossed Above 20 DMA Bullish -5.18%
    Crossed Above 50 DMA Bullish -5.18%
    MACD Bullish Signal Line Cross Bullish -5.18%
    Narrow Range Bar Range Contraction -5.18%
    Inside Day Range Contraction -5.18%
    Older End-of-Day Signals for ABSI ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance about 21 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    Rose Above 20 DMA about 22 hours ago
    Up 1% about 22 hours ago
    10 DMA Support about 23 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ABSI Chart by TradingView
    Basic chart:

    Profile

    Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Genscript Biotech

    Is ABSI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Absci (ABSI) to Report Q1 Earnings: Here's What to Expect
    May 2 CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?
    Apr 16 Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
    Apr 10 Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
    Mar 28 Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    Mar 23 Absci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net Loss
    Mar 22 6 Analysts Assess Absci: What You Need To Know
    Mar 21 Absci GAAP EPS of -$0.25 misses by $0.01, revenue of $0.34M misses by $0.69M
    Mar 21 Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
    Mar 12 11 Stocks Insiders are Buying Now
    See more ABSI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.72
    52 Week Low 1.1111
    Average Volume 1,448,764
    200-Day Moving Average 3.10
    50-Day Moving Average 5.17
    20-Day Moving Average 5.02
    10-Day Moving Average 4.90
    Average True Range 0.38
    RSI (14) 47.64
    ADX 16.2
    +DI 24.11
    -DI 19.58
    Chandelier Exit (Long, 3 ATRs) 5.57
    Chandelier Exit (Short, 3 ATRs) 5.42
    Upper Bollinger Bands 5.87
    Lower Bollinger Band 4.18
    Percent B (%b) 0.45
    BandWidth 33.54
    MACD Line -0.07
    MACD Signal Line -0.08
    MACD Histogram 0.0179
    Fundamentals Value
    Market Cap 459.12 Million
    Num Shares 92.9 Million
    EPS -1.16
    Price-to-Earnings (P/E) Ratio -4.26
    Price-to-Sales 57.61
    Price-to-Book 1.94
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.38
    Resistance 3 (R3) 5.38 5.24 5.30
    Resistance 2 (R2) 5.24 5.13 5.24 5.28
    Resistance 1 (R1) 5.09 5.06 5.17 5.09 5.25
    Pivot Point 4.95 4.95 4.99 4.95 4.95
    Support 1 (S1) 4.80 4.84 4.88 4.80 4.63
    Support 2 (S2) 4.66 4.77 4.66 4.60
    Support 3 (S3) 4.51 4.66 4.58
    Support 4 (S4) 4.51